Comparison between Akums Drugs IPO and Brainbees Solutions IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Brainbees Solutions IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Brainbees Solutions IPO is up to ₹4,193.73 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Brainbees Solutions IPO is ₹465.00 per share.
| Akums Drugs IPO | Brainbees Solutions IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹440.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹465.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹465.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | ₹44.00 per share |
| Market Lot Size | 22 shares | 32 shares |
| Fresh Issue Size | 1,00,37,708 shares | 3,58,34,699 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹1,666.19 Cr |
| OFS Issue Size | 1,73,30,435 shares | 5,43,59,733 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹2,527.54 Cr |
| Issue Size Total | 2,73,68,143 shares | 9,01,94,432 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹4,193.73 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Brainbees Solutions IPO opens on Aug 06, 2024. The closing date of Akums Drugs IPO and Brainbees Solutions IPO is Aug 01, 2024, and Aug 08, 2024, respectively.
| Akums Drugs IPO | Brainbees Solutions IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Aug 05, 2024 |
| Issue Open | Jul 30, 2024 | Aug 06, 2024 |
| Issue Close | Aug 01, 2024 | Aug 08, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Aug 09, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Aug 12, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Aug 12, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Aug 13, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Sep 08, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Nov 07, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Brainbees Solutions IPO P/E ratio of -69.91.
| Akums Drugs IPO | Brainbees Solutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | -69.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹24141.75 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-6.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | -8.65% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Brainbees Solutions IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 2,70,36,953 shares in Brainbees Solutions IPO.
| Akums Drugs IPO | Brainbees Solutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 4,05,55,428 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 2,70,36,953 shares |
| NII | 40,68,637 shares | 1,35,18,476 shares |
| RII | 27,12,424 shares | 90,12,317 shares |
| Employee | 2,43,902 shares | 71,258 shares |
| Others | ||
| Total | 2,73,68,151 shares | 9,01,94,432 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Brainbees Solutions IPO subscribed 12.22x.
| Akums Drugs IPO | Brainbees Solutions IPO | |
|---|---|---|
| QIB (times) | 90.09x | 19.30x |
| NII (times) | 42.10x | 4.68x |
| Big NII (times) | 47.43x | 5.32x |
| Small NII (times) | 31.45x | 3.39x |
| RII (times) | 20.80x | 2.31x |
| Employee (times) | 4.14x | 6.57x |
| Other (times) | ||
| Total (times) | 63.44x | 12.22x |
